Dr Maynard's review article (June 2000 JRSM, pp. 288± 291) was both interesting and relevant. I was in London during the 1952 smog and can remember trying to feel my way around Clapham Common during what seemed to be perpetual dusk. The accepted explanation for the 4000 or so excess deaths in the 1952 smog was that they were caused by air pollutants compromising lung function. My next two and a half years were spent in Shef®eld in junior hospital posts. In those days, between October and March, Shef®eld seemed to be perpetually smog-ridden with Had®elds and Steel, Peach and Tozer incessantly spewing fumes into the air. Every winter there was a constant¯ow of`blue bloaters' with cor pulmonale requiring admission to the Royal In®rmary and City General Hospital. Many died despite' supplemental oxygen, bronchodilators and excellent nursing care. At about the same time, Dr Charles Davies who was a reader in Professor Charles Stuart-Harris's Department of Medicine was measuring the cerebrospinal¯uid (CSF) pressure in such individuals on and off additional oxygen. He observed that a substantial number of those with chronic bronchitis and emphysema became drowsy and hypoventilated, while their CSF pressure went way up and some developed papilloedema. It was, however, left to Moran Campbell and Keith Westlake to demonstrate that administration of excess oxygen could cause severe hypoventilation and apnoea. In retrospect one wonders how many deaths in the 1952 smog were iatrogenic, precipitated by the administration of excess oxygen. Unfortunately, many recent medical graduates seem unaware that they need to be careful when prescribing oxygen in chronic obstructive respiratory failure lest they precipitate hypoventilation and severe carbon dioxide retention. It would seem that Moran Campbell's superb 1967 Amberson Lecture to the American Thoracic Society is forgotten or at least passe Â, no doubt partly because we see far fewer blue bloaters these days. 
Roses red and white
Describing the creation of the coat of arms for our new College, Bernard Valman records that some Lancastrians objected to the inclusion of a white rose (July 2000 JRSM, p. 389) and explains that the white rose had been choseǹ because it represented the City of York . . . as well as the rose of England'. This perpetuates the original mistake. The rose of England is red not white, as a glance at an England rugby player's jersey or the emblem of the Labour Party will reveal. The white rose is the rose of the House of York . . . who, yes, did lose the Battle of the Roses. Alongside the daffodil, the thistle and the shamrock should be the red rose. Like Dr Pearce (June 2000 JRSM, p. 335±336) I suspect that he had cerebral palsy. In daily rehabilitation practice we know that even patients with`stable non-deteriorating' disabilities can worsen slowly over the yearsÐfor example, those with spinal cord injury, amputees, post-polio patients. This is true of patients with cerebral palsy. Claudius experienced bouts of`meteoria'Ðthe petit mal seizures or absences typical of brain damage. He was described as drooling, which is not a feature of dystonia (Dr Rice's proposal).
M Y Anthony
For me, as a rehabilitation physician, Claudius' historic achievement was to decree freedom for wounded or disabled soldier-slaves or gladiators, who were treated at the Valetudinaria on the small island of St Bartholomew in the River Tiber. . Issues such as apartheid, the death penalty in the USA, and torture were also discussed, and there was unanimous agreement, following my suggestion, that a working group should be set up to study the ethical issues of medical involvement in these horrors. Perhaps of even greater concern to your readers will be the following facts. There is still continued use of the Pernkopf Atlas by Austrian medical students. The illustrations in this atlas are thought to be based on concentration camp victims, with the original artists using SS symbols in their signatures. There is also the unresolved case of Dr Heinrich Gross, an Austrian doctor accused of killing children in a Nazi euthanasia centre. Many of the brains removed from these children are still standing in an Austrian anatomical museum and cannot be buried until the case of Dr Gross is ®nally concluded. He recently claimed inability to plead at a court case and subsequently walked free. He then gave a perfectly coherent interview to the media, delighting in the case's outcome.
Finally, it is extremely sad that an Austrian, Professor Wolfgang Neugebauer, who is looking into many of these unresolved`medical issues', has had a case of defamation of character brought against him by Dr Jorg Haider, supported by the Austrian minister of justice.
I feel that your readers should be aware of some of these issues, on which I would be happy to supply further details.
Lotte Newman
The White House, 1 Ardwick Road, London NW2 2BX, UK
Experimental allergic encephalomyelitis and multiple sclerosis
Dr J N Blau makes some very good points in his review of Books of the Body: Anatomical Ritual and Renaissance Learning (August 2000 JRSM, pp. 446±447). The inertia in accepting new ideas is not con®ned to medicine. Before the notion of chemical elements could be accepted, the previous ideas of Aristotle (that the earth was composed of four elements) had to be discarded; this took many hundreds of years. New ideas are never very welcome. When Isaac Newton was professor of mathematics at Cambridge, no students attended his lectures.
Dr Blau considers that the production of experimental allergic encephalomyelitis (EAE) in monkeys, and the classi®cation of multiple sclerosis as autoimmune, did not help patients and may even have hindered progress. This is because of gaps in our knowledge of these conditions. American researchers in neuropathology have told me that EAE owes its discovery to the fact that in 1935 many monkeys in American laboratories had tuberculosis. The original experimental results have never been successfully reproduced; since then, Freund's complete adjuvant or a similar agent has been used at some stage in the experiments.
One source of error or misunderstanding is the fact that experimental pathologists and clinicians use the word relapse to mean different things. The relapses in multiple sclerosis occur about once every 15 months; and, since this is an average, the intervals will often be much longer. By contrast, in animals such as rats, with whole myelin used as the antigen, three or four relapses may occur in 2±3 months. This enormous difference indicates that the two types of relapse are completely different phenomena. When a relapse involves the human eye, the condition is called retrobulbar neuritis. I have never seen this described in animals, even monkeys. In humans it is associated with marked swelling of the optic nerve and 
